In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic control-Reference-Cited by-同舟云学术

In type 1 diabetics, high-dose biotin may compensate for low hepatic insulin exposure, promoting a more normal expression of glycolytic and gluconeogenic enyzymes and thereby aiding glycemic control

Published:2016-10 Issue: Volume:95 Page:45-48
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

McCarty Mark F.

Publisher

Elsevier BV

Subject

General Medicine

Reference47 articles.

1. Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus;Aoki;Lancet,1993

2. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production;Barzilai;Diabetes,1996

3. High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes;McCarty;Med Hypotheses,1999

4. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression;Dentin;J Biol Chem,2004

5. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver;Yamashita;Proc Natl Acad Sci USA,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Antioxidant Potential of Vitamins and Their Implication in Metabolic Abnormalities;Nutrients;2024-08-16

2. Molecular Mechanisms of Biotin in Modulating Inflammatory Diseases;Nutrients;2024-07-27

3. Crocin Ameliorates Diabetic Nephropathy through Regulating Metabolism, CYP4A11/PPARγ, and TGF-β/Smad Pathways in Mice;Current Drug Metabolism;2023-10

4. Evaluation of efficacy and safety of glucokinase activators—a systematic review and meta-analysis;Frontiers in Endocrinology;2023-05-08

5. Physiological Associations between Vitamin B Deficiency and Diabetic Kidney Disease;Biomedicines;2023-04-11